Publication

Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.

Busch, Susann
; 
Rydén, L
; 
Stål, O
; 
Jirström, K
; 
Landberg, Göran
Citations
Altmetric:
Abstract
The aim of this study was to evaluate ERK phosphorylation as a stromal biomarker for breast cancer prognosis and tamoxifen treatment prediction within a randomized tamoxifen trial.
Authors
Busch, Susann
Rydén, L
Stål, O
Jirström, K
Landberg, Göran
Affiliation
Breakthrough Breast Cancer Research Unit, School of Cancer, Enabling Sciences and Technology, University of Manchester, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Description
Date
2012
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Type
Article
Citation
Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer. 2012, 7 (9):e45669 PLoS ONE
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/262494
Embedded videos